Alpha Tau Medical Ltd. (DRTS)
NCM · Healthcare · Biotechnology
$14.43
-0.07%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.33B
Shares Outstanding
92.5M
Exchange
NCM
Currency
USD
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (10.7M) | (12.6M) | (13.3M) | (13.8M) |
| Net Income | (11.7M) | (12.1M) | (22.9M) | (45.8M) |
| Diluted EPS | N/A | N/A | $-0.26 | N/A |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (32.1M) | (35.7M) | (36.0M) | (42.3M) |
| Net Income | (33.8M) | (29.2M) | (31.8M) | (42.6M) |
| Diluted EPS | $-0.53 | $-0.42 | $-0.45 | N/A |